Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ºÚÁÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Novel approach for the formulation of excipient-less fixed dose combination (FDC) tablets by Hot Melt Extrusion (HME) technology using quality by design approach
4th International Pharma & Clinical Pharmacy Congress
The objectives of the present study were to investigate the properties of HME based tablets containing plain ibuprofenparacetamol
FDC, without a single excipient and to compare it with marketed formulation by applying QbD approach.
Paracetamol and ibuprofen were taken at drug/drug mass ratios (5:2). The prepared physical mixtures were extruded using
a corotating twin-screw hot melt extrusion. Among the three tested independent variables in DOE, temperature and feeding
rate most significantly affected the tensile strength and drug release from the tablet. The melt extruded granules were passed
through a 250�¼m sieve. The maximum optimized ratio (85:5.5:100) determined by DOE was chosen for further analysis. DSC,
XRD, SEM were carried out to determine physicochemical changes after melt granulation. The granules were characterized
for particle size analysis, flow properties, granule strength. Tablets containing 500 mg paracetamol and 200 mg ibuprofen were
compressed at 10.0kN compaction force. The tablets were characterized for tablet hardness, friability, disintegration time and
dissolution study. All results were found to be within acceptable USP limits. The optimized extruded batch was stable at 400C,
75%RH for a period of 6 months without changing any dissolution rate and remained into amorphous state.